Garzotto F, Ostermann M, Martín-Langerwerf D, Sánchez-Sánchez M, Teng J, Robert R, Marinho A, Herrera-Gutierrez M E, Mao H J, Benavente D, Kipnis E, Lorenzin A, Marcelli D, Tetta C, Ronco C
Department of Nephrology Dialysis and Transplantation, San Bortolo Hospital, 37 Via Rodolfi, 36100, Vicenza, Italy.
International Renal Research Institute of Vicenza (IRRIV), San Bortolo Hospital, 37 Via Rodolfi, 36100, Vicenza, Italy.
Crit Care. 2016 Jun 23;20(1):196. doi: 10.1186/s13054-016-1355-9.
The previously published "Dose Response Multicentre International Collaborative Initiative (DoReMi)" study concluded that the high mortality of critically ill patients with acute kidney injury (AKI) was unlikely to be related to an inadequate dose of renal replacement therapy (RRT) and other factors were contributing. This follow-up study aimed to investigate the impact of daily fluid balance and fluid accumulation on mortality of critically ill patients without AKI (N-AKI), with AKI (AKI) and with AKI on RRT (AKI-RRT) receiving an adequate dose of RRT.
We prospectively enrolled all consecutive patients admitted to 21 intensive care units (ICUs) from nine countries and collected baseline characteristics, comorbidities, severity of illness, presence of sepsis, daily physiologic parameters and fluid intake-output, AKI stage, need for RRT and survival status. Daily fluid balance was computed and fluid overload (FO) was defined as percentage of admission body weight (BW). Maximum fluid overload (MFO) was the peak value of FO.
We analysed 1734 patients. A total of 991 (57 %) had N-AKI, 560 (32 %) had AKI but did not have RRT and 183 (11 %) had AKI-RRT. ICU mortality was 22.3 % in AKI patients and 5.6 % in those without AKI (p < 0.0001). Progressive fluid accumulation was seen in all three groups. Maximum fluid accumulation occurred on day 2 in N-AKI patients (2.8 % of BW), on day 3 in AKI patients not receiving RRT (4.3 % of BW) and on day 5 in AKI-RRT patients (7.9 % of BW). The main findings were: (1) the odds ratio (OR) for hospital mortality increased by 1.075 (95 % confidence interval 1.055-1.095) with every 1 % increase of MFO. When adjusting for severity of illness and AKI status, the OR changed to 1.044. This phenomenon was a continuum and independent of thresholds as previously reported. (2) Multivariate analysis confirmed that the speed of fluid accumulation was independently associated with ICU mortality. (3) Fluid accumulation increased significantly in the 3-day period prior to the diagnosis of AKI and peaked 3 days later.
In critically ill patients, the severity and speed of fluid accumulation are independent risk factors for ICU mortality. Fluid balance abnormality precedes and follows the diagnosis of AKI.
先前发表的“剂量反应多中心国际协作倡议(DoReMi)”研究得出结论,急性肾损伤(AKI)的危重症患者高死亡率不太可能与肾替代治疗(RRT)剂量不足有关,其他因素在起作用。这项随访研究旨在调查每日液体平衡和液体蓄积对接受足量RRT的无AKI(N-AKI)、有AKI(AKI)和有AKI且接受RRT(AKI-RRT)的危重症患者死亡率的影响。
我们前瞻性纳入了来自9个国家21个重症监护病房(ICU)的所有连续入院患者,并收集了基线特征、合并症、疾病严重程度、脓毒症的存在情况、每日生理参数和液体出入量、AKI分期、RRT需求和生存状态。计算每日液体平衡,液体超负荷(FO)定义为入院体重(BW)的百分比。最大液体超负荷(MFO)为FO的峰值。
我们分析了1734例患者。共有991例(57%)为N-AKI,560例(32%)有AKI但未接受RRT,183例(11%)有AKI-RRT。AKI患者的ICU死亡率为22.3%,无AKI患者为5.6%(p<0.0001)。三组均出现了渐进性液体蓄积。N-AKI患者在第2天出现最大液体蓄积(BW的2.8%),未接受RRT的AKI患者在第3天出现(BW的4.3%),AKI-RRT患者在第5天出现(BW的7.9%)。主要发现为:(1)MFO每增加1%,医院死亡率的比值比(OR)增加1.075(95%置信区间1.055-1.095)。在调整疾病严重程度和AKI状态后,OR变为1.044。这一现象是连续的,且与先前报道的阈值无关。(2)多变量分析证实液体蓄积速度与ICU死亡率独立相关。(3)在AKI诊断前3天内液体蓄积显著增加,并在3天后达到峰值。
在危重症患者中,液体蓄积的严重程度和速度是ICU死亡率的独立危险因素。液体平衡异常在AKI诊断之前和之后均存在。